Akoya Biosciences Inc
1505 O'Brien
Menlo Park
California
94025
United States
85 articles about Akoya Biosciences Inc
-
Akoya Reports Second Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
8/8/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the second quarter ending June 30, 2022.
-
Akoya to Participate at Two Upcoming Investor Conferences
7/27/2022
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced that it will be participating in two upcoming investor conferences.
-
Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022
7/12/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will release financial results for the second quarter of 2022 after the market close on Monday, August 8th, 2022.
-
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
6/28/2022
The OncoSignature ® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers.
-
Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting
6/1/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, will present for the first time, data generated using its proprietary RNA chemistry, which enables whole-slide spatial multiomics at single-cell resolution on the PhenoCycler-Fusion system, at the Advances in Genome Biology and Technology conference in Orlando, Florida, from June 6 to 9.
-
Akoya Reports First Quarter 2022 Operating Results and Raises Full Year 2022 Revenue Guidance
5/5/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the first quarter ending March 31, 2022.
-
Akoya to Participate at Three Upcoming Investor Conferences - May 03, 2022
5/3/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be participating in three upcoming investor conferences.
-
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.
-
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
4/19/2022
Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company ® , today announced the appointment of Dr. Ehab A. El-Gabry as the company’s Chief Medical Officer (CMO).
-
Akoya to Report First Quarter 2022 Financial Results on May 5th, 2022
4/14/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will release financial results for the first quarter of 2022 after the market close on Thursday, May 5th, 2022.
-
Akoya Biosciences to Showcase New Data on PhenoCycler-Fusion at the AACR Annual Meeting 2022
4/6/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced that two important milestones on advancing the speed and scale of its spatial phenotyping solutions, will be presented during the American Association for Cancer Research 2022 Annual Meeting in New Orleans, April 8 to 13.
-
Akoya Reports Fourth Quarter and Full Year 2021 Operating Results and Provides 2022 Financial Outlook
3/14/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the fourth quarter and full year ending December 31, 2021.
-
Akoya to Report Fourth Quarter and Full Year 2021 Financial Results on March 14th, 2022 and Present at the Cowen Annual Health Care Conference on March 8th, 2022
2/22/2022
Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter and full year of 2021 after the market close on Monday, March 14th, 2022.
-
Akoya Biosciences to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
2/3/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will be virtually participating in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.
-
BioSpace Movers & Shakers, Jan. 21
1/21/2022
Biopharma and life sciences companies made numerous appointments this week to boards and executive teams. These Movers & Shakers will position the companies for future growth. -
Akoya Biosciences Appoints Marilee Moy as Chief People Officer
1/20/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced the appointment of Marilee Moy as Chief People Officer.
-
Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System
1/13/2022
Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, today announced the commercial availability of the PhenoCycler™-Fusion system, setting a new standard in spatial biology for high-speed imaging of whole slides, at single-cell and sub-cellular resolution.
-
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2021
1/10/2022
Akoya Biosciences, Inc., The Spatial Biology Company®, announced preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2021.
-
Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
1/5/2022
Bio-Techne and Akoya Biosciences, Inc. announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.
-
Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
1/5/2022
Akoya Biosciences, Inc., and Bio-Techne today announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.